£1.2M
Northstar Ventures led the £1.2m round to support the commercial rollout of the medtech firm's diagnostic device.
Manus Neurodynamica develops digital health tools to detect early signs of neurological conditions.
Manus Neurodynamica develops diagnostic medical devices and digital tools for neurological conditions. Its signature product evaluates hand and limb movements to assist with the detection of Parkinson disease.
Rutger Zietsma
CEO
Northstar Ventures led the £1.2m round to support the commercial rollout of the medtech firm's diagnostic device.